Needles Are Out, Future Tech Is In, For Blood Glucose Measurement
Medtech Insight has spoken to several companies aiming to release devices that will replace current blood glucose monitors via disruptive, innovative technologies.
You may also be interested in...
The Israeli company touts its GWave monitor as the world's first non-invasive continuous glucose monitoring technology that uses radiofrequency waves to measure glucose levels in the blood.
The company has developed a biosensor that provides information to health care professionals concerning the health of a patient’s wound.
Babson recently raised $31m to accelerate commercialization of its blood testing “ecosystem,” developed with help from Siemens Healthineers and Becton Dickinson.